title: [Solcoseryl® – mechanism and risks].
abstract: Solcoseryl® is a protein-free haemodialysate, containing a broad spectrum of low molecular components of cellular mass and blood serum obtained from veal calves. Solcoseryl® improves the transport of oxygen and glucose to cells that are under hypoxic conditions. It increases the synthesis of intracellular ATP and contributes to an increase in the level of aerobic glycolysis and oxidative phosphorylation. It activates the reparative and regenerative processes in tissues by stimulating fibroblast proliferation and repair of the collagen vascular wall. The formulations of Solcoseryl® are infusion, injection, gel and ointment, and it is also available as a dental paste for inflammatory processes of the mouth cavity, gums and lips.
authors.affiliation: Clinique et policlinique de chirurgie buccale et maxillo-faciale, Centre de médecine dentaire de lUniversité de Zurich, Zurich, Switzerland.
authors.forename: Ayhan
authors.initials: A
authors.lastname: Yildirim
authors.forename: Philipp
authors.initials: P
authors.lastname: Metzler
authors.forename: Martin
authors.initials: M
authors.lastname: Lanzer
authors.forename: Heinz-Theo
authors.initials: HT
authors.lastname: Lübbers
authors.forename: Vedat
authors.initials: V
authors.lastname: Yildirim
keywords: Solcoseryl®; Pâte adhésive bucco-dentaire